Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB) (NCT06779825)
Impact of Stimulants and In-Scanner Motion on FMRI Neurofeedback and Task Performance in ADHD
🩺 Plain-English Summary (8th-Grade Level)
The goal of this interventional study is to learn the effects that stimulant medication prescribed to ADHD individuals has in their performance of attentive tasks, as measured by images and data collected through neuroimaging (fMRI) while also implementing new motion-correcting software. The main questions it aims to answer are: 1. How do the use of stimulants affect brain activity and motion in fMRI research in ADHD studies? 2. Can neurofeedback, an attentive task using real-time brain activity, engage the same brain circuits as seen with stimulant medication in individuals with ADHD? Researchers will compare participant's brain activity from the completion of attentive tasks performed in the scanner while following their regular medication regimen and while abstaining to take medication. Researchers will also compare how the data collected using a more precise motion correction software differs to other previously reported data from ADHD studies who possibly employed more lenient measures of motion correction. Participants will: 1. Be asked to complete at least 4 fMRI sessions, two of which will include neurofeedback 2. Be asked to abstain from taking stimulant medication on the day of two of these fMRI visits 3. Complete attentive tasks while in the scanner that will activate target brain regions of interest
Who can join: Review the eligibility criteria below.
Location: Boston Children's Hospital @2BP — Brookline, Massachusetts
Age range: 12 Years to 35 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Boston Children's Hospital @2BP — Brookline, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 355-6000
Email: alexander.cohen2@childrens.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in ADHD
- Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom — Miami, Florida
- Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing — Los Angeles, California
- A Trial of Two-Week Brain Stimulation for Teenagers With ADHD — East Providence, Rhode Island
- tRNS Treatment for ADHD Symptoms — Boston, Massachusetts
- Efficacy of an Occupational Intervention for Improving Quality of Work Life in Adults Living With ADHD — Montreal, Quebec
- Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial — College Park, Maryland
Explore by condition: All ADHD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.